Mapping of quantitative trait loci determining NK cell-mediated resistance to MHC class I-deficient bone marrow grafts in perforin-deficient mice

Journal of Immunology

Volumn 177, Issue 11, 2006, Pages 7923-7929

  Johansson, Maria H ^a,b   Taylor, Mesha A ^a   Jagodic, Maja ^b   Tus, Katalin ^c   Schatzle, John D ^a   Wakeland, Edward K ^c   Bennett, Michael ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MICROSATELLITE DNA; PERFORIN;

ANIMAL EXPERIMENT; ARTICLE; BONE MARROW TRANSPLANTATION; CHROMOSOME 2; CHROMOSOME 3; CHROMOSOME 4; CHROMOSOME 8; CONTROLLED STUDY; EPISTASIS; GENE LOCUS; GENE MAPPING; GRAFT REJECTION; IMMUNOREGULATION; KNOCKOUT MOUSE; MOUSE; NATURAL KILLER CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; QUANTITATIVE TRAIT LOCUS;

EID: 33751558424     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.11.7923     Document Type: Article

References (63)

1. Yu, Y. Y., V. Kumar, and M. Bennett. 1992. Murine natural killer cells and marrow graft rejection. Annu. Rev. Immunol. 10: 189-213.
2. Lanier, L. L. 2005. NK cell recognition. Annu. Rev. Immunol. 23: 225-274.
3. Zompi, S., and F. Colucci. 2005. Anatomy of a murder - signal transduction pathways leading to activation of natural killer cells. Immunol. Lett. 97: 31-39.
4. Colucci, F., E. Schweighoffer, E. Tomasello, M. Turner, J. R. Ortaldo, E. Vivier, V. L. Tybulewicz, and J. P. Di Santo. 2002. Natural cytotoxicity uncoupled from the Syk and Zap-70 intracellular kinases. Nat. Immunol. 3: 288-294.
5. Gazit, R., R. Gruda, M. Elboim, T. I. Arnon, G. Katz, H. Achdout, J. Hanna, U. Qimron, G. Landau, E. Greenbaum, et al. 2006. Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. 7: 517-523.
6. Lowin, B., M. C. Peitsch, and J. Tschopp. 1995. Perforin and granzymes: crucial effector molecules in cytolytic T lymphocyte and natural killer cell-mediated cytotoxicity. Curr. Top. Microbiol. Immunol. 198: 1-24.
7. Lieberman, J. 2003. The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal. Nat. Rev. Immunol. 3: 361-370.
8. van den Broek, M. F., D. Kagi, R. M. Zinkernagel, and H. Hengartner. 1995. Perforin dependence of natural killer cell-mediated tumor control in vivo. Eur. J. Immunol. 25: 3514-3516.
9. Kagi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369: 31-37.
10. Smyth, M. J., K. Y. Thia, E. Cretney, J. M. Kelly, M. B. Snook, C. A. Forbes, and A. A. Scalzo. 1999. Perforin is a major contributor to NK cell control of tumor metastasis. J. Immunol. 162: 6658-6662.
11. Mori, S., A. Jewett, K. Murakami-Mori, M. Cavalcanti, and B. Bonavida. 1997. The participation of the Fas-mediated cytotoxic pathway by natural killer cells is tumor-cell-dependent. Cancer Immunol. Immunother. 44: 282-290.
12. Arase, H., N. Arase, and T. Saito. 1995. Fas-mediated cytotoxicity by freshly isolated natural killer cells. J. Exp. Med. 181: 1235-1238.
13. Zamai, L., M. Ahmad, I. M. Bennett, L. Azzoni, E. S. Alnemri, and B. Perussia. 1998. Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells. J. Exp. Med. 188: 2375-2380.
14. Kayagaki, N., N. Yamaguchi, M. Nakayama, K. Takeda, H. Akiba, H. Tsutsui, H. Okamura, K. Nakanishi, K. Okumura, and H. Yagita. 1999. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells. J. Immunol. 163: 1906-1913.
15. Screpanti, V., R. P. Wallin, H. G. Ljunggren, and A. Grandien. 2001. A central role for death receptor-mediated apoptosis in the rejection of tumors by NK cells. J. Immunol. 167: 2068-2073.
16. Smyth, M. J., E. Cretney, K. Takeda, R. H. Wiltrout, L. M. Sedger, N. Kayagaki, H. Yagita, and K. Okumura. 2001. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon γ-dependent natural killer cell protection from tumor metastasis. J. Exp. Med. 193: 661-670.
17. Hayakawa, Y., V. Screpanti, H. Yagita, A. Grandien, H. G. Ljunggren, M. J. Smyth, and B. J. Chambers. 2004. NK cell TRAIL eliminates immature dendritic cells in vivo and limits dendritic cell vaccination efficacy. J. Immunol. 172: 123-129.
18. Lee, R. K., J. Spielman, D. Y. Zhao, K. J. Olsen, and E. R. Podack. 1996. Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells. J. Immunol. 157: 1919-1925.
19. Baker, M. B., E. R. Podack, and R. B. Levy. 1995. Perforin- and Fas-mediated cytotoxic pathways are not required for allogeneic resistance to bone marrow grafts in mice. Biol. Blood Marrow. Transplant. 1: 69-73.
20. Bennett, M., P. A. Taylor, M. Austin, M. B. Baker, L. B. Schook, M. Rutherford, V. Kumar, E. R. Podack, K. M. Mohler, R. B. Levy, and B. R. Blazar. 1998. Cytokine and cytotoxic pathways of NK cell rejection of class 1-deficient bone marrow grafts: influence of mouse colony environment. Int. Immunol. 10: 785-790.
21. Taylor, M. A., B. Ward, J. D. Schatzle, and M. Bennett. 2002. Perforin- and Fas-dependent mechanisms of natural killer cell-mediated rejection of incompatible bone marrow cell grafts. Eur. J. Immunol. 32: 793-799.
22. Pinti, M., J. Pedrazzi, F. Benatti, V. Sorrentino, C. Nuzzo, V. Cavazzuti, P. Biswas, D. N. Petrusca, C. Mussini, B. De Rienzo, and A. Cossarizza. 1999. Differential down-regulation of CD95 or CD95L in chronically HIV-infected cells of monocytic or lymphocytic origin: cellular studies and molecular analysis by quantitative competitive RT-PCR. FEBS Lett. 458: 209-214.
23. Taylor, M. A., P. M. Chaudhary, J. Klem, V. Kumar, J. D. Schatzle, and M. Bennett. 2001. Inhibition of the death receptor pathway by cFLIP confers partial engraftment of MHC class I-deficient stem cells and reduces tumor clearance in perforin-deficient mice. J. Immunol. 167: 4230-4237.
24. Bennett, M. 1971. Graft-versus-host reactions in mice. I. Kinetic and immunogenetic studies of alloantigen-sensitive units of lymphoid tissue. Transplantation 11: 158-169.
25. + T cells and NK cells in irradiated mice. J. Immunol. 155: 3742-3749.
26. Broman, K. W., H. Wu, S. Sen, and G. A. Churchill. 2003. R/qtl: QTL mapping in experimental crosses. Bioinformatics 19: 889-890.
27. Churchill, G. A., and R. W. Doerge. 1994. Empirical threshold values for quantitative trait mapping. Genetics 138: 963-971.
28. Visscher, P. M., R. Thompson, and C. S. Haley. 1996. Confidence intervals in QTL mapping by bootstrapping. Genetics 143: 1013-1020.
29. Sentman, C. L., V. Kumar, G. Koo, and M. Bennett. 1989. Effector cell expression of NK1.1, a murine natural killer cell-specific molecule, and ability of mice to reject bone marrow allografts. J. Immunol. 142: 1847-1853.
30. Brown, M. G., A. A. Scalzo, K. Matsumoto, and W. M. Yokoyama. 1997. The natural killer gene complex: a genetic basis for understanding natural killer cell function and innate immunity. Immunol. Rev. 155: 53-65.
31. Makrigiannis, A. P., A. T. Pau, A. Saleh, R. Winkler-Pickett, J. R. Ortaldo, and S. K. Anderson. 2001. Class I MHC-binding characteristics of the 129/J Ly49 repertoire. J. Immunol. 166: 5034-5043.
32. Makrigiannis, A. P., A. T. Pau, P. L. Schwartzbeig, D. W. McVicar, T. W. Beck, and S. K. Anderson. 2002. A BAC contig map of the Ly49 gene cluster in 129 mice reveals extensive differences in gene content relative to C57BL/6 mice. Genomics 79: 437-444.
33. Makrigiannis, A. P., D. Patel, M.-L. Goulet, K. Dewar, and S. K. Anderson. 2005. Direct sequence comparison of two divergent class I MHC natural killer cell receptor haplotypes. Genes Immun. 6: 71-83.
34. McVicar, D. W., R. Winkler-Pickett, L. S. Taylor, A. Makrigiannis, M. Bennett, S. K. Anderson, and J. R. Ortaldo. 2002. Aberrant DAP12 signaling in the 129 strain of mice: implications for the analysis of gene-targeted mice. J. Immunol. 169: 1721-1728.
35. Raziuddin, A., D. L. Longo, L. Mason, J. R. Ortaldo, M. Bennett, and W. J. Murphy. 1998. Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets. J. Immunol. 160: 87-94.
36. George, T. C., L. H. Mason, J. R. Ortaldo, V. Kumar, and M. Bennett. 1999. Positive recognition of MHC class I molecules by the Ly49D receptor of murine NK cells. J. Immunol. 162: 2035-2043.
37. Oberg, L., S. Johansson, J. Michaelsson, E. Tomasello, E. Vivier, K. Karre, and P. Hoglund. 2004. Loss or mismatch of MHC class I is sufficient to trigger NK cell-mediated rejection of resting lymphocytes in vivo - role of KARAP/DAP12-dependent and -independent pathways. Eur. J. Immunol. 34: 1646-1653.
38. Ogasawara, K., J. Benjamin, R. Takaki, J. H. Phillips, and L. L. Lanier. 2005. Function of NKG2D in natural killer cell-mediated rejection of mouse bone marrow grafts. Nat. Immunol. 6: 938-945.
39. Takeda, K., E. Cretney, Y. Hayakawa, T. Ota, H. Akiba, K. Ogasawara, H. Yagita, K. Kinoshita, K. Okumura, and M. J. Smyth. 2005. TRAIL identifies immature natural killer cells in newborn mice and adult mouse liver. Blood 105: 2082-2089.
40. Sato, K., S. Hida, H. Takayanagi, T. Yokochi, N. Kayagaki, K. Takeda, H. Yagita, K. Okumura, N. Tanaka, T. Taniguchi, and K. Ogasawara. 2001. Antiviral response by natural killer cells through TRAIL gene induction by IFN-α/β. Eur. J. Immunol. 31: 3138-3146.
41. + regulatory T cells. Proc. Natl. Acad. Sci. USA 103: 5460-5465.
42. Kim, M. H., R. P. Kitson, P. Albertsson, U. Nannmark, P. H. Basse, P. J. Kuppen, M. E. Hokland, and R. H. Goldfarb. 2000. Secreted and membrane-associated matrix metalloproteinases of IL-2-activated NK cells and their inhibitors. J. Immunol. 164: 5883-5889.
43. Fiore, E., C. Fusco, P. Romero, and I. Stamenkovic. 2002. Matrix metalloproteinase 9 (MMP-9/gelatinase B) proteolytically cleaves ICAM-1 and participates in tumor cell resistance to natural killer cell-mediated cytotoxicity. Oncogene 21: 5213-5223.
44. Mitsiades, N., W. H. Yu, V. Poulaki, M. Tsokos, and I. Stamenkovic. 2001. Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity. Cancer Res. 61: 577-581.
45. Schneider, P., N. Holler, J.-L. Bodmer, M. Hahne, K. Frei, A. Fontana, and J. Tschopp. 1998. Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity. J. Exp. Med. 187: 1205-1213.
46. + T cells. Immunity 16: 779-790.
47. + T cells through Stat1-dependent and -independent mechanisms. Proc. Natl. Acad. Sci. USA 100: 15047-15052.
48. Nguyen, K. B., T. P. Salazar-Mather, M. Y. Dalod, J. B. Van Deusen, X.-q. Wei, F. Y. Liew, M. A. Caligiuri; J. E. Durbin, and C. A. Biron. 2002. Coordinated and distinct roles for IFN-αβ, IL-12, and IL-15 regulation of NK cell responses to viral infection. J. Immunol. 169: 4279-4287.
49. Kennedy, M. K., M. Glaccum, S. N. Brown, E. A. Butz, J. L. Viney, M. Embers, N. Matsuki, K. Charrier, L. Sedger, C. R. Willis, et al. 2000. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice. J. Exp. Med. 191: 771-780.
50. Lodolce, J. P., D. L. Boone, S. Chai, R. E. Swain, T. Dassopoulos, S. Trettin, and A. Ma. 1998. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation. Immunity 9: 669-676.
51. Thomis, D. C., and L. J. Berg. 1997. The role of Jak3 in lymphoid development, activation, and signaling. Curr. Opin. Immunol. 9: 541-547.
52. Notarangelo, L. D., S. Giliani, C. Mazza, P. Mella, O. Savoldi, C. Rodriguez-Perez, E. Mazzolari, M. Fiorini, M. Duse, A. Plebani, et al. 2000. Of genes and phenotypes: the immunological and molecular spectrum of combined immune deficiency: defects of the gc-JAK3 signaling pathway as a model. Immunol. Rev. 178: 39-48.
53. Frucht, D. M., M. Gadina, G. J. Jagadeesh, I. Aksentijevich, K. Takada, J. J. Bleesing, J. Nelson, L. M. Muul, G. Perham, G. Morgan, et al. 2001. Unexpected and variable phenotypes in a family with JAK3 deficiency. Genes Immun. 2: 422-432.
54. van Pesch, V., H. Lanaya, J. C. Renauld, and T. Michiels. 2004. Characterization of the murine α interferon gene family. J. Virol. 78: 8219-8228.
55. Tassi, I., R. Presti, S. Kim, W. M. Yokoyama, S. Gilfillan, and M. Colonna. 2005. Phospholipase C-γ2 is a critical signaling mediator for murine NK cell activating receptors. J. Immunol. 175: 749-754.
56. Caraux, A., N. Kim, S. E. Bell, S. Zompi, T. Ranson, S. Lesjean-Pottier, M. E. Garcia-Ojeda, M. Turner, and F. Colucci. 2005. Phospholipase C-γ2 is essential for NK cell cytotoxicity and innate immunity to malignant and virally infected cells. Blood 107: 994-1002.
57. Cella, M., K. Fujikawa, I. Tassi, S. Kim, K. Latinis, S. Nishi, W. Yokoyama, M. Colonna, and W. Swat. 2004. Differential requirements for Vav proteins in DAP10- and ITAM-mediated NK cell cytotoxicity. J. Exp. Med. 200: 817-823.
58. Pardo, J., M. Buferne, M. J. Martinez-Lorenzo, J. Naval, A. M. Schmitt-Verhulst, C. Boyer, and A. Anel. 2003. Differential implication of protein kinase C isoforms in cytotoxic T lymphocyte degranulation and TCR-induced Fas ligand expression. Int. Immunol. 15: 1441-1450.
59. Furuke, K., M. Shiraishi, H. S. Mostowski, and E. T. Bloom. 1999. Fas ligand induction in human NK cells is regulated by redox through a calcineurin-nuclear factors of activated T cell-dependent pathway. J. Immunol. 162: 1988-1993.
60. Samson, S. I., O. Richard, M. Tavian, T. Ranson, C. A. Vosshenrich, F. Colucci, J. Buer, F. Grosveld, I. Godin, and J. P. Di Santo. 2003. GATA-3 promotes maturation, IFN-γ production, and liver-specific homing of NK cells. Immunity 19: 701-711.
61. MacMicking, J. D. 2004. IFN-inducible GTPases and immunity to intracellular pathogens. Trends Immunol. 25: 601-609.
62. Miller, K., S. McArdle, M. J. Gale, Jr., D. A. Geller, B. Tenoever, J. Hiscott, D. R. Gretch, and S. J. Polyak. 2004. Effects of the hepatitis C virus core protein on innate cellular defense pathways. J. Interferon Cytokine Res. 24: 391-402.
63. Carter, C. C., V. Y. Gorbacheva, and D. J. Vestal. 2005. Inhibition of VSV and EMCV replication by the interferon-induced GTPase, mGBP-2: differential requirement for wild-type GTP binding domain. Arch. Virol. 150: 1213-1220.